Evidence map›Paper›PMID 33554610›Full record

SynthesisCirculation2021

Variation in the Proportion of Adults in Need of Blood Pressure-Lowering Medications by Hypertension Care Guideline in Low- and Middle-Income Countries: A Cross-Sectional Study of 1 037 215 Individuals From 50 Nationally Representative Surveys.

Nikkil Sudharsanan, Michaela Theilmann, Tabea K Kirschbaum, Jennifer Manne-Goehler, Sina Azadnajafabad, Pascal Bovet, Simiao Chen, Albertino Damasceno, Jan-Walter De Neve, Maria Dorobantu and 18 more

Open access · greenAbstract readMeta-Analysis
In one paragraph

Synthesis in Circulation, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Advances in pathogenesis and treatment of essential hypertension.Frontiers in cardiovascular medicine · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors at 1 institution in 1 country.

Nikkil SudharsananHeidelberg Institute of Global Health, Heidelberg University, Germany (N.S., M.T., T.K.K., S.C., J.-W.D.N., J.L., T.B.).
Michaela TheilmannHeidelberg Institute of Global Health, Heidelberg University, Germany (N.S., M.T., T.K.K., S.C., J.-W.D.N., J.L., T.B.).
Tabea K KirschbaumHeidelberg Institute of Global Health, Heidelberg University, Germany (N.S., M.T., T.K.K., S.C., J.-W.D.N., J.L., T.B.).
Jennifer Manne-GoehlerDivision of Infectious Diseases, Massachusetts General Hospital, Harvard Medical School, Boston (J.M.-G.).
Sina AzadnajafabadTehran University of Medical Sciences, Iran (S.A., F.F., K.J., S.S.M.).
Pascal BovetInstitute of Social and Preventive Medicine, Bern, Switzerland (P.B.).
Simiao ChenHeidelberg Institute of Global Health, Heidelberg University, Germany (N.S., M.T., T.K.K., S.C., J.-W.D.N., J.L., T.B.).
Albertino DamascenoFaculty of Medicine, Eduardo Mondlane University, Maputo, Mozambique (A.D.).
Jan-Walter De NeveHeidelberg Institute of Global Health, Heidelberg University, Germany (N.S., M.T., T.K.K., S.C., J.-W.D.N., J.L., T.B.).
Maria DorobantuCardiology Department, Emergency Hospital of Bucharest, Romania (M.D.).
Cara EbertRWI-Leibniz Institute for Economic Research, Essen, Germany (C.E.).
Farshad FarzadfarTehran University of Medical Sciences, Iran (S.A., F.F., K.J., S.S.M.).
Gladwell GathechaDivision of Non-Communicable Diseases, Ministry of Health, Nairobi, Kenya (G.G.).
Mongal Singh GurungHealth Research and Epidemiology Unit, Ministry of Health, Thimphu, Bhutan (M.S.G.).
Kosar JamshidiTehran University of Medical Sciences, Iran (S.A., F.F., K.J., S.S.M.).
Jutta M A JørgensenD-Tree International, Norwell, MA (J.M.A.J.).
Demetre LabadariosFaculty of Medicine and Health Sciences, Stellenbosch University, South Africa (D.L.).
Julia LempHeidelberg Institute of Global Health, Heidelberg University, Germany (N.S., M.T., T.K.K., S.C., J.-W.D.N., J.L., T.B.).
Nuno LunetDepartment of Public and Forensic Health Sciences and Medical Education, Faculty of Medicine, University of Porto, Portugal (N.L.).
Joseph K MwangiDepartment of Strategic National Public Health Programs, Ministry of Health, Nairobi, Kenya (J.K.M.).
Sahar Saeedi MoghaddamTehran University of Medical Sciences, Iran (S.A., F.F., K.J., S.S.M.).
Silver K BahendekaSaint Francis Hospital, Kampala, Uganda (S.K.B.).
Zhaxybay ZhumadilovNational Laboratory Astana, University Medical Centre, Nazarbayev University, Kazakhstan (Z.Z.).
Till BärnighausenHeidelberg Institute of Global Health, Heidelberg University, Germany (N.S., M.T., T.K.K., S.C., J.-W.D.N., J.L., T.B.).
Sebastian VollmerDepartment of Economics and Centre for Modern Indian Studies, University of Göttingen, Germany (S.V.).
Rifat AtunDepartment of Global Health and Population, Harvard T.H. Chan School of Public Health, Harvard University, Boston, MA (R.A.).
Justine I DaviesInstitute of Applied Health Research, University of Birmingham, United Kingdom (J.I.D.).
Pascal GeldsetzerDivision of Primary Care and Population Health, Department of Medicine, Stanford University, CA (P.G.).
Eduardo Mondlane University · MZ

Funding

Institutional Career Development Core (KL2)KL2TR003143 · NCATS · STANFORD UNIVERSITY · PI ASCH, STEVEN M. · 2019 to 2023
$8.7M
European Research Council 850896NCATS NIH HHS KL2 TR003143
6 · The paper itself

Abstract

backgroundCurrent hypertension guidelines vary substantially in their definition of who should be offered blood pressure-lowering medications. Understanding the effect of guideline choice on the proportion of adults who require treatment is crucial for planning and scaling up hypertension care in low- and middle-income countries.

methodsWe extracted cross-sectional data on age, sex, blood pressure, hypertension treatment and diagnosis status, smoking, and body mass index for adults 30 to 70 years of age from nationally representative surveys in 50 low- and middle-income countries (N = 1 037 215). We aimed to determine the effect of hypertension guideline choice on the proportion of adults in need of blood pressure-lowering medications. We considered 4 hypertension guidelines: the 2017 American College of Cardiology/American Heart Association guideline, the commonly used 140/90 mm Hg threshold, the 2016 World Health Organization HEARTS guideline, and the 2019 UK National Institute for Health and Care Excellence guideline.

resultsThe proportion of adults in need of blood pressure-lowering medications was highest under the American College of Cardiology/American Heart Association, followed by the 140/90 mm Hg, National Institute for Health and Care Excellence, and World Health Organization guidelines (American College of Cardiology/American Heart Association: women, 27.7% [95% CI, 27.2-28.2], men, 35.0% [95% CI, 34.4-35.7]; 140/90 mm Hg: women, 26.1% [95% CI, 25.5-26.6], men, 31.2% [95% CI, 30.6-31.9]; National Institute for Health and Care Excellence: women, 11.8% [95% CI, 11.4-12.1], men, 15.7% [95% CI, 15.3-16.2]; World Health Organization: women, 9.2% [95% CI, 8.9-9.5], men, 11.0% [95% CI, 10.6-11.4]). Individuals who were unaware that they have hypertension were the primary contributor to differences in the proportion needing treatment under different guideline criteria. Differences in the proportion needing blood pressure-lowering medications were largest in the oldest (65-69 years) age group (American College of Cardiology/American Heart Association: women, 60.2% [95% CI, 58.8-61.6], men, 70.1% [95% CI, 68.8-71.3]; World Health Organization: women, 20.1% [95% CI, 18.8-21.3], men, 24.1.0% [95% CI, 22.3-25.9]). For both women and men and across all guidelines, countries in the European and Eastern Mediterranean regions had the highest proportion of adults in need of blood pressure-lowering medicines, whereas the South and Central Americas had the lowest.

conclusionsThere was substantial variation in the proportion of adults in need of blood pressure-lowering medications depending on which hypertension guideline was used. Given the great implications of this choice for health system capacity, policy makers will need to carefully consider which guideline they should adopt when scaling up hypertension care in their country.

Indexed as

AdultAgedAntihypertensive AgentsBlood PressureCross-Sectional StudiesFemaleGuidelines as TopicHumansHypertensionMaleMiddle AgedPovertyRisk FactorsSocial ClassAntihypertensive Agentshealth policyhypertensiontherapeutics

Identifiers

PMID33554610
PMCPMC7940589
OpenAlexW3126414378

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.